yttrium radioisotopes has been researched along with Stomach Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ćwikła, JB; Kolasińska-Ćwikła, A; Maciejkiewicz, KM; Łowczak, A | 1 |
| Avery, RJ; Hennemeyer, CT; Kuo, PH; Nia, BB; Nia, ES | 1 |
| Bergsma, H; de Herder, WW; Kam, BL; Krenning, EP; Kwekkeboom, DJ; Peeters, RP; Teunissen, JJ; van Vliet, EI | 1 |
| Cacciari, G; Campana, D; Capurso, G; Delle Fave, G; Falconi, M; Nori, F; Panzuto, F; Partelli, S; Tamburrino, D; Tomassetti, P | 1 |
| Calabrese, L; Crosta, C; Grana, C; Martinelli, G; Paganelli, G; Pinto, A; Pruneri, G; Radice, D; Rizzo, S; Vanazzi, A | 1 |
| Bailey, DL; Clarke, SJ; Lee, A; Li, BT | 1 |
| Kosiek, O; Lippert, H; Meyer, F; Pech, M; Schulz, HU; Strach, K | 1 |
| Becker, M; Brod, KH; Dähnert, W; Grimm, W; Kutzner, J; Schreyer, T | 1 |
| Malygina, AI; Nikitina, RG | 1 |
| Beyer, GJ; Bockisch, A; Grimm, W; Hahn, K; Kutzner, J; Rösler, HP | 1 |
| Courtenay-Luck, NS; Epenetos, AA; Gooden, CS; Kosmas, C; McCall, MJ; Meares, CF; Snook, D | 1 |
2 review(s) available for yttrium radioisotopes and Stomach Neoplasms
| Article | Year |
|---|---|
Peptide Receptor Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors - from oncology perspective.
Topics: Humans; Intestinal Neoplasms; Lutetium; Neuroendocrine Tumors; Pancreatic Neoplasms; Radioisotopes; Receptors, Peptide; Stomach Neoplasms; Yttrium Radioisotopes | 2018 |
[Intracavitary administration of liquid radioisotopes].
Topics: Abdominal Neoplasms; Female; Gold Colloid, Radioactive; Humans; Injections, Intraperitoneal; Intestinal Neoplasms; Neoplasm Metastasis; Ovarian Neoplasms; Radiotherapy; Stomach Neoplasms; Yttrium Radioisotopes | 1978 |
2 trial(s) available for yttrium radioisotopes and Stomach Neoplasms
| Article | Year |
|---|---|
Efficacy of ⁹⁰Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Prospective Studies; Radioimmunotherapy; Recurrence; Rituximab; Salvage Therapy; Stomach Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2014 |
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Topics: Aged; Antibodies; Antibodies, Monoclonal; Antibody Formation; Breast; Breast Neoplasms; Chelating Agents; Drug Evaluation; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Stomach Neoplasms; Testicular Neoplasms; Yttrium Radioisotopes | 1992 |
7 other study(ies) available for yttrium radioisotopes and Stomach Neoplasms
| Article | Year |
|---|---|
Punctate Radiation Dermatitis of the Foot and Ankle Caused by Distal Embolization of 90Y Microspheres During Liver Directed Therapy.
Topics: Adenocarcinoma; Adult; Ankle; Dermatitis; Embolization, Therapeutic; Foot; Humans; Liver Neoplasms; Male; Microspheres; Radiation Injuries; Radiometry; Stomach Neoplasms; Yttrium Radioisotopes | 2017 |
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.
Topics: Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Somatostatin; Retreatment; Somatostatin; Stomach Neoplasms; Yttrium Radioisotopes | 2012 |
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.
Topics: Aged; Female; Humans; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Radiopharmaceuticals; Somatostatin; Stomach Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2013 |
PET monitoring of liver directed selective internal radionuclide therapy for metastatic gastro-oesophageal cancer.
Topics: Aged; Esophageal Neoplasms; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Yttrium Radioisotopes | 2016 |
[Finding-specific minimally invasive approach for acute radiation-induced cholecystitis after (90)Y-radioembolisation of intrahepatic metastases].
Topics: Acute Disease; Biopsy; Brachytherapy; Cholecystitis; Combined Modality Therapy; Cooperative Behavior; Embolization, Therapeutic; Follow-Up Studies; Gallbladder; Humans; Interdisciplinary Communication; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neoplasms, Multiple Primary; Radiation Injuries; Radiotherapy, Adjuvant; Rectal Neoplasms; Stomach Neoplasms; Yttrium Radioisotopes | 2013 |
[Treatment of pains from bone metastases with 90Y (author's transl)].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Stomach Neoplasms; Yttrium Radioisotopes | 1981 |
[Scintigraphic use of 87Y during 90Y therapy of bone metastases].
Topics: Aged; Bone Neoplasms; Carcinoma, Bronchogenic; Humans; Lung Neoplasms; Male; Middle Aged; Prostatic Neoplasms; Radionuclide Imaging; Stomach Neoplasms; Yttrium Radioisotopes | 1992 |